American International Group, Inc. Angion Biomedica Corp. Transaction History

American International Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.1 - $2.23 $11,887 - $24,099	-10,807 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.72 - $2.96 $1,310 - $2,255	-762 Reduced 6.59%	10,807 $23,000
Q4 2021 Feb 11, 2022	SELL	$2.35 - $9.95 $813 - $3,442	-346 Reduced 2.9%	11,569 $34,000
Q3 2021 Nov 12, 2021	BUY	$9.31 - $13.25 $80,643 - $114,771	8,662 Added 266.28%	11,915 $116,000
Q2 2021 Aug 13, 2021	SELL	$13.02 - $17.83 $1,705 - $2,335	-131 Reduced 3.87%	3,253 $42,000
Q1 2021 May 07, 2021	BUY	$15.01 - $25.74 $50,793 - $87,104	3,384 New	3,384 $61,000

Ticker ANGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,113,300
Description
Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primaril...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.